ANTI-CD20 ANTIBODIES AND THERAPEUTIC USES THEREOF

Provided herein are novel anti-CD20 antibodies that exhibit several advantageous properties as compared to rituximab.

Saved in:
Bibliographic Details
Main Authors DESJARLAIS, John, R, BERNETT, Matthew, MOORE, Gregory
Format Patent
LanguageEnglish
French
German
Published 30.08.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Provided herein are novel anti-CD20 antibodies that exhibit several advantageous properties as compared to rituximab.
Bibliography:Application Number: EP20210807446